Home Latest News WHO Recommends Twice-a-Year Injection for HIV Prevention: A Game-Changer in Global Fight Against the Virus
Latest NewsWHO

WHO Recommends Twice-a-Year Injection for HIV Prevention: A Game-Changer in Global Fight Against the Virus

Share
WHO
WHO
Share

New Delhi, 15 July 2025: In a landmark move aimed at curbing the global spread of HIV, the World Health Organization (WHO) has officially recommended a long-acting injectable medication to administered twice a year for HIV prevention. This breakthrough offers a powerful alternative to daily oral pills, especially for people at high risk of infection who struggle with daily medication adherence. The injectable, which provides sustained protection, could transform the way HIV prevention approached. Particularly in regions with high transmission rates and limited access to regular healthcare.

What Is the New HIV Prevention Injection and How It Works

The injectable drug, known as cabotegravir long-acting (CAB-LA), is a type of pre-exposure prophylaxis (PrEP) — a preventive approach where HIV-negative individuals take medication to avoid infection. Administered every six months, CAB-LA works by maintaining effective drug levels in the body that block the virus from replicating if exposed. Clinical trials have shown that it is highly effective in preventing HIV, offering up to 79% more protection compared to daily oral PrEP pills in some high-risk populations. Its long-acting nature means fewer doses, reduced pill fatigue, and better privacy — key benefits for those concerned about stigma or inconsistent access.

Why the WHO’s Endorsement Is a Major Public Health Milestone

WHO’s endorsement of the twice-yearly injection seen as a major step in the global effort to end HIV as a public health threat. Millions of people, especially in low- and middle-income countries, face barriers to consistent use of daily PrEP due to stigma, forgetfulness, travel, or lack of health services. By shifting to a biannual injection, health systems can improve adherence rates and reduce new infections more effectively. The move also aligns with WHO’s broader goal of expanding access to diverse, client-centered HIV prevention tools tailored to individual needs and lifestyles.

Who Can Benefit Most from the Twice-Yearly HIV Injection

The injection particularly suited for people at ongoing substantial risk of HIV. Including men who have sex with men, transgender individuals, sex workers, serodiscordant couples, and young women in high-prevalence areas. Adolescents and people facing gender-based or sexual violence may also benefit from a discreet, long-acting prevention method that doesn’t require daily attention. The convenience of only two injections per year can help reduce drop-out rates from PrEP programs and offer protection for individuals who may find it hard to access or adhere to oral PrEP regimens.

Access, Equity, and the Need for Global Rollout

Despite the promise of the twice-yearly injection, access remains a key challenge. The injectable PrEP is currently expensive and limited in availability, especially in low-resource settings. WHO has called on governments, pharmaceutical companies, and global health donors to scale up production, reduce costs, and integrate CAB-LA into national HIV prevention strategies. Equitable access is essential to ensure that the benefits of this medical advancement reach the communities that need it most. Efforts are also underway to train healthcare workers, raise awareness, and address stigma surrounding PrEP and HIV.

The Future of HIV Prevention: Simpler, Stronger, and More Inclusive

The WHO’s recommendation reflects a shift toward more personalized, long-acting HIV prevention strategies that prioritize ease, privacy, and effectiveness. With proper funding and political will, twice-yearly injectable PrEP could drastically reduce new infections and help achieve global HIV targets. As more people gain access to this innovation, it can serve as a powerful tool in reversing the epidemic’s trajectory and protecting vulnerable populations around the world.

The twice-yearly HIV prevention injection marks a turning point in public health strategy, offering hope for millions at risk of infection. With strong evidence supporting its effectiveness and WHO’s backing, this intervention could reshape HIV prevention programs worldwide. However, the success of this advancement depends on affordability, access, and inclusive implementation. As the world races to end the HIV epidemic, this long-acting injectable brings us one step closer to that goal.

Share
Written by
kirti Shah

Kirti is a Health Editor at Healthwire Media, specializing in health journalism and digital health communication. With over four years of experience in the healthcare media landscape, she is dedicated to transforming complex clinical data into accessible, patient-friendly information. Kirti oversees the editorial lifecycle of every article, ensuring they meet rigorous fact-checking standards and align with the latest guidelines from primary sources like the WHO and Ministry of Health. In her role, Kirti works closely with a panel of board-certified physicians and medical reviewers to ensure that every piece of content published is not only easy to understand but also medically accurate and safe for the public. She is passionate about health literacy and helping readers navigate their wellness journeys with confidence.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Always Tired? It Could Be Anaemia!
Diet & NutritionHealth NewsHealth TipsLifestyleLifestyle & WellnessWellness

Anaemia in India: Why Iron Deficiency Remains a Concern and 7 Signs You Should Not Ignore

Feeling tired all the time, experiencing frequent dizziness or getting breathless after climbing a few stairs? While these symptoms are often dismissed as...

N95 Mask
Health TipsLatest NewsLifestyle & WellnessWellness

Does Wearing an N95 Mask Protect You From PM2.5 Pollution? Doctors Explain How To Choose And Wear It Correctly

As air pollution continues to affect several Indian cities during winter, wearing a mask has become an important precaution for people stepping outdoors....

Delhi Air Pollution
Lifestyle & Wellness

Can Air Pollution Cause Pneumonia? Doctors Explain How Poor AQI Affects Your Lungs This Winter

Winter brings a familiar set of respiratory health concerns, from persistent coughing and throat irritation to breathing difficulties and chest infections. However, as...

Diet & NutritionHealth TipsLatest NewsLifestyleLifestyle & WellnessWellness

Weight Loss Diet: 10 Drinks That May Help You Lose Weight

Losing weight is not just about eating healthy and exercising. What you drink during the day also matters. Some drinks can help you...

Heart Attack
Lifestyle & Wellness

Diabetes and Heart Disease: Why High Blood Sugar Can Increase Your Risk of a Heart Attack

Diabetes is often considered a condition that primarily affects blood sugar levels. However, its impact extends far beyond glucose regulation. Persistently high blood...

Section title

Related Articles
Latest NewsWHO

WHO Releases First-Ever Guidelines For Type 1 Diabetes In Adults: 5 Key Recommendations Explained

The World Health Organization (WHO) has issued its first-ever guidelines for the...

Health NewsLatest NewsLifestyle

7 Simple Ways to Protect Yourself from Air Pollution

Air pollution has become a major health concern today. Dust from construction...